Updated: Cancer treatment firm Burning Rock kicks off $209m US IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Updated: Cancer treatment firm Burning Rock kicks off $209m US IPO

Jonathan Breen
June 08, 2020 09:30 AM
Wall_street_Adobe_575x375_230420

Burning Rock Biotech, a cancer detection and therapy company, has opened books for its up to $209.3m Nasdaq IPO following a hot week for Chinese listings in the US.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquity IPOsHealth and BiotechEquityChina Merchants Bank CoChinaAmericasJefferies LLCHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificNorth AmericaSRIBank of AmericaMorgan StanleyUnited StatesEmerging MarketsGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article